Metrics of salbutamol use as predictors of future adverse outcomes in asthma

M. Weatherall, M. Patel, J. Pilcher, H. Reddel, D. Shaw, R. Beasley (Wellington, New Zealand; Nottingham, United Kingdom; Sydney, Australia)

Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Session: Quality of diagnosis and assessment in primary care
Session type: Poster Discussion
Number: 278
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Weatherall, M. Patel, J. Pilcher, H. Reddel, D. Shaw, R. Beasley (Wellington, New Zealand; Nottingham, United Kingdom; Sydney, Australia). Metrics of salbutamol use as predictors of future adverse outcomes in asthma. Eur Respir J 2013; 42: Suppl. 57, 278

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predictors of exacerbations in asthma
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015


Oral corticosteroids in asthma exacerbations: Differences between patient-reported data and proxies from claims data
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016


Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013


Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015


Bronchial thermoplasty in patients with very severe asthma: Safety and clinical outcomes
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016


Risk for adverse outcomes in asthma: Assess to impress!
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


Assessing the risk of future severe asthma exacerbations using CARAT questionnaire and lung function
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013


Respiratory effectiveness group study: Predictors of frequent severe asthma exacerbations
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015


Predictors of good inhaler technique in asthma and COPD
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


Assessing asthma risk in primary care: Can the AAA test predict future asthma attacks?
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014

Factors related with hospitalizations due to asthma exacerbations
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015


Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013

Identifying patients at risk for future exacerbations of asthma: Development of a prediction model
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015

Barriers to adherence to asthma medication
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015


Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014


The parameters that may affect inhalation therapy success in elderly COPD and asthma patients
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015


Adherence with inhaled corticosteroids in asthma: Does pregnancy lead to improved adherence?
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014

Prognostic factors of mortality and cardiovascular outcomes in the tiotropium safety and performance in respimat (TIOSPIR) trial
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013


Real-life asthma impairment: SABA use depends on smoking phenotype
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013